<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 12 Jun 2026 16:08:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: JENKINS GEORGE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+JENKINS+GEORGE+M/26640781.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640781.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+JENKINS+GEORGE+M/26640781.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: JENKINS GEORGE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+JENKINS+GEORGE+M/26640781.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640781.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+JENKINS+GEORGE+M/26640781.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: KIRITSY CHRISTOPHER P</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+KIRITSY+CHRISTOPHER+P/26640786.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640786.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+KIRITSY+CHRISTOPHER+P/26640786.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: KIRITSY CHRISTOPHER P</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+KIRITSY+CHRISTOPHER+P/26640786.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640786.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+KIRITSY+CHRISTOPHER+P/26640786.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: Davis Todd C</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Davis+Todd+C/26640709.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640709.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Davis+Todd+C/26640709.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: Davis Todd C</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Davis+Todd+C/26640709.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640709.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Davis+Todd+C/26640709.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: Doux John</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Doux+John/26640735.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640735.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Doux+John/26640735.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: Doux John</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Doux+John/26640735.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640735.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Doux+John/26640735.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: HERON ELAINE J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+HERON+ELAINE+J/26640743.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640743.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+HERON+ELAINE+J/26640743.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: HERON ELAINE J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+HERON+ELAINE+J/26640743.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640743.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+HERON+ELAINE+J/26640743.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: Wessel Tadd S.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Wessel+Tadd+S./26640669.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640669.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Wessel+Tadd+S./26640669.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>Form  4          PALVELLA THERAPEUTICS,    For: Jun 10  Filed by: Wessel Tadd S.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Wessel+Tadd+S./26640669.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640669.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PALVELLA+THERAPEUTICS%2C++++For%3A+Jun+10++Filed+by%3A+Wessel+Tadd+S./26640669.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
  <item>
   <title>ResVita Bio adds dermatologist John Doux to board of directors</title>
   <link>http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</link>
   <description>

&lt;p&gt;ResVita Bio, a Berkeley-based biotechnology company, announced the appointment of John D. Doux, M.D., M.B.A., to its board of directors. The company develops topical cell therapy treatments using genetically engineered bacteria to produce therapeutic proteins for skin diseases.&lt;/p&gt;

&lt;p&gt;Doux is a board-certified dermatologist and Fellow of the American Academy of Dermatology. He currently serves as an analyst at Palo Alto Investors LP, a healthcare-focused investment firm, and sits on the boards of Palvella Therapeutics (NASDAQ: PVLA) and Orvida Pharma. He previously maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.&lt;/p&gt;

&lt;p&gt;The appointment comes as ResVita prepares to begin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/ResVita+Bio+adds+dermatologist+John+Doux+to+board+of+directors/26621045.html</guid>
   <pubDate>Tue, 09 Jun 2026 08:43:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03607790</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.11608963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27140355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27952506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216916</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012013</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00285300</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05010326</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20147506</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.24990922</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38236026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52413133</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56853832</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PVLA</category>
   	  </item>
 </channel>
</rss>
